Lecture 21+22+DLA Flashcards

1
Q

meta analysis

A

the combination of many studies to combine results

can obtain a more precise estimate of effect size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which of the following is an advantage of the random effects model over the fixed effect model?

A

It gives more realistic results when there is heterogeneity among studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Temporality

A

the exposure occurred before the outcome

the exposure could be due to the outcome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Strength of Association

A

measured by risk ratio and rate ratio

A strong association is more likely to be causal

A strong association is unlikely to be due to
undetected confounding or bias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Consistency

A

An association found in several different studies
with different study designs carried out under
different circumstances with different populations

more likely to be causal
less likely to have bias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Reversibility

A

Experimental evidence to show that the removal of the exposure leads to a reduction in the risk of the outcome

Provides very strong evidence in favor of a
causal relationship

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Multi-causality

A

The multi-causal paradigm is the dominant theory of causation in contemporary epidemiology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Random Error/ Chance

A

Random error reflects a problem of precision in assessing a given exposure-disease relationship and can be reduced by increasing the sample size

affects internal validity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Systematic Error/ Bias

A

reflects a problem of validity of the study

selection bias:
Methods used by the investigator when recruiting
individuals for the study, from factors affecting the
study participation

information bias:
Systematic distortions when collecting information
about exposures and outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

recall bias

A

example of information bias

the ability to recall past exposure is dependent on case or control status

ex: inaccuracy of memory / peer interference

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

response bias

A

anything in a survey that would influence a response

can be question bias or interviewer bias

Ex: lack of privacy while doing survey

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Berkson’s bias

A

a form of selection bias that impacts hospital based studies

the hospital population is atypical compared to the normal population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

healthy worker effect

A

found in work-force studies

results in better health status than the general population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

hawthorne effect

A

the subject will change their behavior due to the fact they are being observed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

lead time bias

A

seems to improve survival time, but just increases disease time

use mortality instead of survival rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

length time bias

A

outcome appears better in screened group because more have a better prognosis

count all outcomes

17
Q

compliance bias

A

outcome in screened group appear better just due to compliance, not screening

count all outcomes

18
Q

confounding bias

A

a systematic distortion in the measure of an association is distorted

confusion of effects

19
Q

B-cells: what type of antigen

A

protein, carb, lipid, NA

20
Q

T-cells: what type of antigen

A

peptide fragments (protein)

antigen must first be processed by APC (dendritic cell)

21
Q

How do antigen and lymphocytes meet?

A

secondary lymphoid tissue

22
Q

MHC

A

cell surface molecule that is required for:
antigen processing
antigen presentation
graft rejection

found in chromosome 6; HLA gene
does not change

23
Q

class I MHC

A

expressed on the majority of nucleated cells

alpha chain: transmembrane (a,b,c)
beta chain: Beta 2 microglobulin

24
Q

MHC 1 binding

A

alpha 3 binds to CD8 on cytotoxic T cells

presents endogenously

alpha 1 and 2 are highly polymorphic

25
Q

class II MHC

A

Alpha 1 and 2 (transmembrane)

beta 1 and 2 (transmembrane)

expressed on all APC’s

26
Q

MHC II binding

A

beta 2 is highly conserved and binds CD4 on helper T cells

Alpha and beta 1 are polymorphic

Alpha 2 is highly conserved

present ag that are in the phagosomes

27
Q

endosomal replication

A

endolytic processing

Ex: strep

28
Q

intracellular replication

A

cytosolic compartment
endogenous processing

ex: viruses (viral antigens)

29
Q

exogenous pathogens

A

Eliminated by:
Antibodies and phagocyte activation by T helper cells that use antigens generated by
ENDOCYTIC PROCESSING

30
Q

endogenous pathogens

A

Eliminated by:
Killing of infected cells by CTL that use antigens generated by
ENDOGENOUS PROCESSING

31
Q

cytosolic pathway

A

endo, non-lysosomal

endogenous antigens are produced in the infected cell
antigens present to Tc cells by MHC I

32
Q

endolytic pathway

A

exo, lysosomal

endolytic antigen- taken in by endocytosis by APC
antigens presented to T-helper by MHC II

33
Q

endogenous Ag processing

A

proteins targeted for lysis are combined with ubiquitin

that ubiquitin-protein complex is degraded by the proteasome

can generate peptides that bind with MHC I

induced by IFN-gamma

34
Q

TAP

A

transporter used for antigen presentation in the endo pathway

go into ER

35
Q

viruses and endo antigen processing

A

viruses can block MHC class I from properly presenting them to the CD8 t cells

cause MHC I degradation

36
Q

HLA-DM

A

mediates the exchange of CLIP for the antigenic peptide

37
Q

cohort study

A

an outcome or disease-free study population is first identified by the exposure or event of interest and followed in time until the disease or outcome of interest
occurs